In Brief: Novo Nordisk's Norditropin
Executive Summary
Novo Nordisk's Norditropin: Ten-day temporary restraining order is issued June 14 on the sale of the company's recently approved human growth hormone product while Brooklyn federal court Judge Constance Baker Motley considers Genentech's motion for preliminary injunction in its patent infringement suit against the Danish firm. Novo had planned to begin shipping Norditropin by June 19. Genentech plans to seek similar restraints against the marketing of BTG's BioTropin approved on May 25...